RPAM
CTIC

Rhenman & Partners Asset Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Rhenman & Partners Asset Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-300,000
Closed -$966K – 96
2020
Q4 		$966K Buy
+300,000
New +$966K 0.08% 82